BÜHLMANN Laboratories AG
Medical Equipment ManufacturingBasel-landschaft, Switzerland51-200 Employees
BÜHLMANN Laboratories AG is a fully independent, mid-sized Swiss company founded in 1976. With local teams in Switzerland, France, Italy, Germany, Austria, the USA, and Brazil, as well as distributors worldwide, BÜHLMANN has established itself as a leader in the field of specialty in-vitro diagnostics. Recent milestone: On June 5, 2024, BÜHLMANN was acquired by KLAR Partners to support the company's continued growth. BÜHLMANN has quickly become a leading provider of calprotectin tests, offering the broadest range of available solutions, including fully automated, high throughput turbidimetric and ELISA assays (BÜHLMANN fCAL® turbo and BÜHLMANN fCAL® ELISA). In addition to calprotectin tests, we also provide therapeutic drug monitoring solutions for biologics used in chronic inflammatory diseases. Our diverse product portfolio includes high-quality assays for routine clinical use, such as the BÜHLMANN Flow CAST® product group for Basophil Activation Testing and the BÜHLMANN GanglioCombi® products, which are the only ELISAs for screening antibodies against gangliosides. We maintain a Quality Management System that is certified according to EN ISO 13485:2016 and MDSAP, and all products are manufactured in accordance with GMP standards. As we enter a new chapter with KLAR Partners, we remain committed to innovation and excellence in the field of in-vitro diagnostics.
1-888-653-2347 
support@leadiq.com 
